Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Purpose. To explore the safety and efficacy of gemcitabine and docetaxel (GEMDOC) in previously treated patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods. Patients with advanced SCCHN previously pretreated with one or two lines of pallia...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kafri, Zyad, Heilbrun, Lance K., Sukari, Ammar, Yoo, George, Jacobs, John, Lin, Ho-Sheng, Mulrenan, Heather, Smith, Daryn, Kucuk, Omer
Formato: Artigo
Idioma:Inglês
Publicado: International Scholarly Research Network 2012
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359684/
https://ncbi.nlm.nih.gov/pubmed/22655205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/159568
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares